Barclays Starts Cellectis (CLLS) at Overweight
(Updated - May 28, 2026 3:43 AM EDT)
Barclays analyst Lukas Shumway initiates coverage on Cellectis (NASDAQ: CLLS) with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Barclays analyst Lukas Shumway initiates coverage on Cellectis (NASDAQ: CLLS) with ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
